LYEL
Lyell Immunopharma Inc
9.60$
-1.1%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +63.5% | +24.1% | -16.8% | -20.0% | -34.6% | -30.7% | |
| – | +40.3% | +1.4% | +4.0% | -14.8% | -31.6% | -31.3% | |
| – | +45.2% | +109.3% | -58.0% | +17.9% | -27.5% | -43.0% | |
| – | +40.5% | +0.4% | +4.1% | -14.7% | -32.2% | -33.3% | |
| – | +183.8% | -3.2% | +38.4% | – | – | – | |
| – | +28.6% | +4.1% | -47.2% | -8.9% | +13.6% | -15.0% | |
| – | +123.6% | -5.2% | -20.8% | -6.8% | +55.8% | -8.1% | |
| – | +951.5% | -67.7% | +287.9% | +38.4% | +27.1% | +13.8% | |
| – | +230.4% | -65.9% | +22.1% | +23.0% | +11.4% | -46.1% | |
| – | +76.1% | +29.4% | -10.4% | -21.4% | -41.5% | -35.2% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | -1.6% | +1.8% | +1.6% | +4.2% | +30.7% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.